Results 211 to 220 of about 669,979 (252)
Some of the next articles are maybe not open access.

Interstitial Lung Diseases

2013
Cystic fibrosis (CF) is the most common autosomal recessive disease among whites, with a frequency of 1 in 2,000 to 1 in 3,000 live births. The disease is caused by a mutation in the gene that encodes for the CF transmembrane conductance regulator on chromosome 7. This mutation causes production of thick, sticky secretions that clog the airways and the
Fabien Maldonado, Timothy R. Aksamit
openaire   +1 more source

Interstitial Lung Disease and Lung Transplantation

Seminars in Respiratory and Critical Care Medicine, 2010
Idiopathic pulmonary fibrosis (IPF) is the most common of the idiopathic interstitial pneumonias and carries the worst prognosis. Currently the best treatment option is lung transplantation. Historically patients with IPF had poor outcomes following referral for lung transplant due to high waiting-list mortality. The introduction of the lung allocation
Sarah L. O’Beirne   +2 more
openaire   +3 more sources

Lung transplantation in interstitial lung disease

Current Opinion in Pulmonary Medicine, 2001
Interstitial lung disease is a heterogeneous group of illnesses, some of which may progress to a fibrosing stage and cause respiratory failure. For selected candidates, lung transplantation is the ultimate therapeutic option. We review data on lung transplantation for various interstitial lung diseases.
Alvin S. Teirstein   +2 more
openaire   +3 more sources

Spectrum of Fibrotic Lung Diseases.

New England Journal of Medicine, 2020
From the Center for Interstitial Lung Diseases and Sarcoidosis, Department of Respiratory Medicine, Erasmus MC–University Medical Center Rotterdam, Rotterdam, the Netherlands (M.W.); and the Department of Respiratory Medicine, National Coordinating ...
L. Salvati, B. Palterer, P. Parronchi
semanticscholar   +1 more source

Lung transplantation for interstitial lung disease

Clinics in Chest Medicine, 2004
Lung transplantation remains the only therapeutic option shown to improve survival for many end-stage interstitial lung diseases. Although idiopathic pulmonary fibrosis is the most common indication, transplantation has been performed for many other diseases.
Sangeeta Bhorade, Brandon Lu
openaire   +2 more sources

Lung transplantation and interstitial lung disease

Current Opinion in Pulmonary Medicine, 2005
Interstitial lung disease includes a heterogeneous group of disorders that leads to respiratory insufficiency and death in a significant number of patients. Lung transplantation is a therapeutic option in select candidates.The indications, transplant procedure options, and outcomes continue to evolve.
Ravinder S Bajwa   +3 more
openaire   +3 more sources

Lung transplantation for interstitial lung diseases

Current Opinion in Pulmonary Medicine, 2014
An overview over the role of lung transplantation in interstitial lung diseases will be given.Lung transplantation is an established therapy option for patients with various end-stage lung diseases. Currently, the worldwide procedural frequency is about 3600 per year.
openaire   +2 more sources

Lung Transplantation for Interstitial Lung Disease

Clinics in Chest Medicine, 2012
For selected parenchymal lung disease patients who fail to respond to medical therapy and demonstrate declines in function that place them at increased risk for mortality, lung transplantation should be considered. Lung transplantation remains a complex medical intervention that requires a dedicated recipient and medical team.
openaire   +3 more sources

Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial.

The Lancet Respiratory Medicine, 2020
A. Wells   +13 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy